Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

Inflammatory Bowel Diseases

Volumn 14, Issue 7, 2008, Pages 949-954

  Punati, Jaya ^a   Markowitz, James ^b   Lerer, Trudy ^c   Hyams, Jeffrey ^c   Kugathasan, Subra ^d   Griffiths, Anne ^e   Otley, Anthony ^f   Rosh, Joel ^g   Pfefferkorn, Marian ^h   Mack, David ⁱ   Evans, Jonathan ^j   Bousvaros, Athos ^k   Susan Moyer, M ^l   Wyllie, Robert ^m   Oliva Hemker, Maria ⁿ   Mezoff, Adam ^o   Leleiko, Neal ^p   Keljo, David ^q   Crandall, Wallace ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b North Shore Long Island Jewish Health System ^*  (United States)

^c Farmington   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f IWK HEALTH CENTRE   (Canada)

^g MORRISTOWN MEMORIAL HOSPITAL   (United States)

^h RILEY HOSPITAL FOR CHILDREN   (United States)

ⁱ CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^j NEMOURS CHILDREN S CLINIC   (United States)

^k BOSTON CHILDREN S HOSPITAL   (United States)

^l CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ JOHNS HOPKINS HOSPITAL   (United States)

^o CHILDREN S MEDICAL CENTER   (United States)

^p HASBRO CHILDREN'S HOSPITAL   (United States)

^q CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

more..

Author keywords

6 Mercaptopurine; Azathioprine; Corticosteroids; Crohn's disease; Hospitalizations; Immunomodulator; Inflammatory bowel disease; Infliximab; Outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; PROBIOTIC AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CHILD HOSPITALIZATION; CHRONOTHERAPY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE SEVERITY; DRUG EFFECT; EARLY INTERVENTION; ENTERIC FEEDING; ENTERITIS; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PEDIATRICS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SCHOOL CHILD; THERAPY DELAY; TREATMENT DURATION; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CHILD; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HOSPITALIZATION; HUMANS; IMMUNOLOGIC FACTORS; MALE; PROSPECTIVE STUDIES;

EID: 44949176312     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20412     Document Type: Article

References (14)

1. Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am. 1999;28:445-458.
2. Calkins BM, Mendeloff AI. Epidemiology of inflammatory bowel disease. Epidemiol Rev. 1986;8:60-91.
3. Markowitz J, Hyams J, Mack D, et al. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol. 2006;4:1124-1129.
4. Steinhart AH, Ewe K, Griffiths AM, et al. Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database System Rev (Online). 2003;CD000301.
5. Rosenberg JL, Levin B, Wall AJ, et al. A controlled trial of azathioprine in Crohn's disease. Am J Digest dis. 1975;20:721-726.
6. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med. 1980;302:981-987.
7. Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology. 1998;115:813-821.
8. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004;127:723-729.
9. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology. 2000;119:895-902.
10. Markowitz J, Grancher K, Mandel F, et al. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum. Am J Gastroenterol. 1993;88:44-48.
11. Meuwissen SG, Ewe K, Gassull MA, et al. IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases. Eur J Gastroenterol Hepatol. 2000;12:13-18.
12. Jaspers GJ, Verkade HJ, Escher JC, et al. Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease. Inflamm Bowel Dis. 2006;12:831-836.
13. Escher JC, Taminiau JA, Nieuwenhuis EE, et al. Treatment of inflammatory bowel disease in childhood: best available evidence. Inflamm Bowel Dis. 2003;9:34-58.
14. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.